4//SEC Filing
Hanlon Suzanne M. 4
Accession 0001192482-21-000110
CIK 0001621443other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:14 PM ET
Size
7.0 KB
Accession
0001192482-21-000110
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Common Stock
2021-01-21+37,000→ 80,693 total - Award
Stock Option (right to buy)
2021-01-21+55,000→ 55,000 totalExercise: $3.58Exp: 2031-01-21→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]These restricted stock units will fully vest on January 21, 2023, subject to continued employment with the Company through the applicable vesting date.
- [F2]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.
Documents
Issuer
Zynerba Pharmaceuticals, Inc.
CIK 0001621443
Entity typeother
Related Parties
1- filerCIK 0001631682
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 4:14 PM ET
- Size
- 7.0 KB